The North America non-invasive aesthetic treatment market size is expected to reach USD 46.07 billion by 2028, according to a new report by the publisher. The market is expected to expand at a CAGR of 13.2% from 2021 to 2028. Non-invasive aesthetic treatments are procedures that do not require surgical intervention, have minimal downtime, lower risks of complications and lower cost of treatment. The market growth is attributed to the rising demand for fillers and injectable including Botox as a result of the increasing target population across the globe. The demand for anti-aging aesthetic solutions that are non-invasive have escalated due to increasing geriatric population pool.
According to the American Society of Plastic Surgeons (ASPS), high growth was observed in facial rejuvenation procedures, and the number of botulinum toxin type A procedures was the highest, accounting for over 7.7 million injections (Botox, Dysport, Xeomin) in 2019. It was also noted that in 2019, around 4,73,354 botulinum toxin filler procedures were performed on men in the U.S. This indicates that demand for the procedure is rapidly increasing among men.
U.S is among the top countries to carry out non-invasive aesthetic treatments globally as the acceptance towards advanced procedures is higher in the country. Moreover rising disposable income, superior medical infrastructure, the prevalence of skin conditions and large pool of aesthetic professionals is expected to boost market growth.
In the light of COVID-19, the global non-invasive aesthetic treatment market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended. The American Society of Plastic Surgeons stated that the pandemic reduced the overall uptake of aesthetic treatments; however, it will be the reason for an upsurge demand for cosmetic procedures in the coming years, which is expected to rise even higher than previous numbers.
U.S is among the top countries to carry out non-invasive aesthetic treatments globally as the acceptance towards advanced procedures is higher in the country. Moreover rising disposable income, superior medical infrastructure, the prevalence of skin conditions and large pool of aesthetic professionals is expected to boost market growth.
In the light of COVID-19, the global non-invasive aesthetic treatment market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended. The American Society of Plastic Surgeons stated that the pandemic reduced the overall uptake of aesthetic treatments; however, it will be the reason for an upsurge demand for cosmetic procedures in the coming years, which is expected to rise even higher than previous numbers.
North America Non-invasive Aesthetic Treatment Market Report Highlights
- The injectable segment held the largest market share in 2020 and is also expected to show the highest CAGR over the forecast period. This is mainly due to the wide applications of aesthetic treatment
- The skin rejuvenation segment held a revenue share of 24.0% in 2020 owing to advancements in procedures like photo rejuvenation, deep chemical peel, and laser resurfacing
- On the basis of end-use, the Medspa segment held the largest revenue share of 34.2% in 2020 because medical esthetic centers are owned and governed by licensed physicians, surgeons, esthetician, and nurses
- U.S dominated the market in 2020, owing to increasing disposable income, high expenditure on healthcare, large pool of certified professionals, and increased prevalence of skin conditions among population
Table of Contents
Chapter 1 Methodology and Scope1.1 Market Segmentation & Scope
1.1.1 Procedure Type
1.1.2 End Use
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 Model Details
1.7.1 QFD Model (Model 1)
1.7.2 Consumer Behavior Market Analysis (Model 2)
1.8 List of Secondary Sources
1.9 List of Primary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective - 1:
1.11.2 Objective - 2:
1.11.3 Objective - 3:
1.11.4 Objective - 4:
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Executive Summary
Chapter 4 U.S. & Canada Non-invasive Aesthetic Treatment Market: Variables, Trends, & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Related/Ancillary Market Outlook
4.1.2.1 Orthodontic consumables
4.1.2.2 Aesthetic laser market
4.1.2.3 Hyaluronic acid dermal filler market
4.1.2.4 Facial injecTables
4.2 Market Segmentation and Scope
4.3 User Perspective Analysis
4.3.1 Consumer Behavior Analysis
4.3.2 Market Influencer Analysis
4.4 Penetration & Growth Prospect Mapping
4.4.1 U.S. Non-Invasive Aesthetic Treatment Market, Penetration & Growth Prospect Mapping
4.4.2 Canada Non-Invasive Aesthetic Treatment Market, Penetration & Growth Prospect Mapping
4.5 Market Driver Analysis
4.5.1 Increasing Beauty Consciousness Among Consumers
4.5.2 Growing Geriatric Population
4.6 Market Restraint Analysis
4.6.1 Lack Of Reimbursement Coverage
4.6.2 Stringent Regulatory Framework
4.7 Porter’s Five Forces Analysis
4.8 PESTEL Analysis
Chapter 5 Impact of COVID-19 on Aesthetics Market
5.1 Impact of COVID-19 on Non-invasive Aesthetic Treatment Market
5.2 Aftermath of COVID-19 Pandemic in Non-invasive Aesthetic Treatment Market
5.2.1 Future Of Aesthetics
Chapter 6 U.S. & Canada Non-invasive Aesthetic Treatment Market: Procedure Type Segment Analysis
6.1 Definitions
6.1.1 Procedure
6.1.1.1 U.S. & Canada Non-invasive Aesthetic Treatment Market: Procedure Type Segment Analysis
6.2 U.S. Non-invasive Aesthetic Treatment: Market Share Analysis, 2020 & 2028
6.3 Canada Non-invasive Aesthetic Treatment: Market Share Analysis, 2020 & 2028
6.4 InjecTable
6.4.1 U.S. InjecTable Market, 2016 - 2028 (USD Million)
6.4.2 Canada InjecTable Market, 2016 - 2028 (USD Million)
6.4.3 Botolinum Toxin
6.4.3.1 U.S.Botulinum Toxin Market, 2016 - 2028 (USD Million)
6.4.3.2 Canada Botulinum Toxin Market, 2016 - 2028 (USD Million)
6.4.4 Calcium Hydroxylapatite (Caha)
6.4.4.1 U.S.Calcium Hydroxylapatite Market, 2016 - 2028 (USD Million)
6.4.4.2 Canada Calcium Hydroxylapatite Market, 2016 - 2028 (USD Million)
6.4.5 Hyaluronic Acid
6.4.5.1 U.S. Hyaluronic Acid Market, 2016 - 2028 (USD Million)
6.4.5.2 Canada Hyaluronic Acid Market, 2016 - 2028 (USD Million)
6.4.6 Polymer Filler
6.4.6.1 U.S. Polymer Fillers Market, 2016 - 2028 (USD Million)
6.4.6.2 Canada Polymer Fillers Market, 2016 - 2028 (USD Million)
6.4.7 Collagen
6.4.7.1 U.S. Collagen Market, 2016 - 2028 (USD Million)
6.4.7.2 Canada Collagen Market, 2016 - 2028 (USD Million)
6.5 Skin Rejuvenation
6.5.1 U.S.Skin Rejuvenation Market 2016 - 2028 (USD Million)
6.5.2 Canadaskin Rejuvenation Market 2016 - 2028 (USD Million)
6.5.3 Chemical Peels
6.5.3.1 U.S. Chemical Peel Market, 2016 - 2028 (USD Million)
6.5.3.2 Canada Chemical Peel Market, 2016 - 2028 (USD Million)
6.5.4 Laser Skin Resurfacing
6.5.4.1 U.S. Laser Skin Resurfacing Market, 2016 - 2028 (USD Million)
6.5.4.2 Canada Laser Skin Resurfacing Market, 2016 - 2028 (USD Million)
6.5.5 Photo Rejuvenation
6.5.5.1 U.S. Photo Rejuvenation Market, 2016 - 2028 (USD Million)
6.5.5.2 Canada Photo Rejuvenation Market, 2016 - 2028 (USD Million)
6.6 Others
6.6.1 U.S. Other Market, 2016 - 2028 (USD Million)
6.6.2 Canada Other Market, 2016 - 2028 (USD Million)
6.6.3 Hair Removal
6.6.3.1 U.S. Hair Removal Market, 2016 - 2028 (USD Million)
6.6.3.2 Canada Hair Removal Market, 2016 - 2028 (USD Million)
6.6.4 Non-Surgical Fat Reduction
6.6.4.1 U.S. Non-Surgical Fat Reduction Market, 2016 - 2028 (USD Million)
6.6.4.2 Canada Non-Surgical Fat Reduction Market, 2016 - 2028 (USD Million)
6.6.5 Sclerotherapy
6.6.5.1 U.S. Sclerotherapy Market, 2016 - 2028 (USD Million)
6.6.5.2 Canada Sclerotherapy Market, 2016 - 2028 (USD Million)
6.6.6 Cellulite Treatment
6.6.6.1 U.S. Cellulite Treatment Market, 2016 - 2028 (USD Million)
6.6.6.2 Canada Cellulite Treatment Market, 2016 - 2028 (USD Million)
Chapter 7 U.S. & Canada Non-invasive Aesthetic Treatment Market: End-use Analysis
7.1 Definitions
7.1.1 End-Use
7.1.1.1 U.S. & Canada Non-Invasive Aesthetic Treatment Market: End-Use Analysis
7.2 U.S. Non-Invasive Aesthetic Treatment: End-Use Market Share Analysis, 2020 & 2028
7.3 Canada Non-Invasive Aesthetic Treatment: End-Use Market Share Analysis, 2020 & 2028
7.3.1 Med Spa
7.3.2 U.S. Medspa Market, 2016 - 2028 (USD Million)
7.3.3 Canada Medspa Market, 2016 - 2028 (USD Million)
7.3.4 Traditional Spa
7.3.4.1 U.S. Traditional Spas Market, 2016 - 2028 (USD Million)
7.3.4.2 Canada Traditional Spas Market, 2016 - 2028 (USD Million)
7.3.5 Hospital/Surgery Center
7.3.5.1 U.S. Hospital And Surgery Center Market, 2016 - 2028 (USD Million)
7.3.5.2 Canada Hospital And Surgery Center Market, 2016 - 2028 (USD Million)
7.3.6 Hcp Owned Clinic
7.3.6.1 U.S. Hcp Owned Clinic Market, 2016 - 2028 (USD Million)
7.3.6.2 Canada Hcp Owned Clinic Market, 2016 - 2028 (USD Million)
Chapter 8 Competitive Analysis
8.1 Company Profiles
8.1.1 TORONTO COSMETIC CLINIC
8.1.1.1 Company Overview
8.1.1.2 Service benchmarking
8.1.2 THE COSMETIC CLINIC
8.1.2.1 COMPANY OVERVIEW
8.1.2.2 Service benchmarking
8.1.3 SKINOVATIVE OF GILBERT - MEDICAL SPA
8.1.3.1 COMPANY OVERVIEW
8.1.3.2 Service benchmarking
8.1.4 SHEA AESTHETIC CLINIC
8.1.4.1 company oVERVIEW
8.1.4.2 Service benchmarking
8.1.5 CHAPTER (REJUV MEDICAL AESTHETIC CLINIC)
8.1.5.1 company oVERVIEW
8.1.5.2 Service benchmarking
8.1.6 ANEWSKIN AESTHETIC CLINIC AND MEDICAL SPA
8.1.6.1 Company OverView
8.1.6.2 Service benchmarking
8.1.7 THE OTTAWA SKIN CLINIC
8.1.7.1 Company Overview
8.1.7.2 Service benchmarking
8.1.8 MANHATTAN AESTHETICS
8.1.8.1 company Overview
8.1.8.2 Service Benchmarking
8.1.9 TORONTO MEDICAL AESTHETICS.
8.1.9.1 company Overview
8.1.9.2 Service Benchmarking
8.1.10 DR. CORY TORGERSON
8.1.10.1 company Overview
8.1.10.2 Service Benchmarking
8.1.11 CANADA MEDLASER INC.
8.1.11.1 company Overview
8.1.11.2 Service Benchmarking
8.1.12 SKINRHÜMMD
8.1.12.1 company Overview
8.1.12.2 Service Benchmarking
8.1.13 SKIN VITALITY MEDICAL CLINIC
8.1.13.1 Company Overview
8.1.13.2 Service Benchmarking
8.1.14 TRUE MEDISPA
8.1.14.1 Company Overview
8.1.14.2 Service Benchmarking
8.1.15 DERMAPURE
8.1.15.1 Company Overview
8.1.15.2 Service BenchmarkingList of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviation
List of Figures
Figure. 1 Market research process
Figure. 2 Information procurement
Figure. 3 Primary research pattern
Figure. 4 Market research approaches
Figure. 5 QFD modeling for market share assessment
Figure. 6 Market formulation & validation
Figure. 7 QFD Analysis
Figure. 8 Consumer Behavior Market Analysis
Figure. 9 U.S. Non-invasive Aesthetic Treatment market snapshot (2020)
Figure. 1 Canada Non-invasive Aesthetic Treatment market snapshot (2020)
Figure. 2 Parent market outlook
Figure. 3 Ancillary market outlook
Figure. 4 U.S. & Canada non-invasive aesthetic treatment market segmentation
Figure. 5 Consumer behavior analysis
Figure. 1 Market influencer analysis
Figure. 2 U.S. Non-invasive Aesthetic Treatment Market, Penetration & growth prospect mapping, End use
Figure. 3 Canada Non-invasive Aesthetic Treatment Market, Penetration & growth prospect mapping, End-use
Figure. 4 Market driver relevance analysis (Current & future impact)
Figure. 5 Market restraint relevance analysis (Current & future impact)
Figure. 6 Porter’s five forces analysis
Figure. 7 SWOT analysis, by factor (political & legal, economic and technological)
Figure. 8 U.S. Non-invasive Aesthetic Treatment market procedure type outlook: Segment dashboard
Figure. 9 U.S. Non-invasive Aesthetic Treatment market: Procedure type movement analysis
Figure. 10 Canada Non-invasive Aesthetic Treatment market procedure type outlook: Segment dashboard
Figure. 11 Canada Non-invasive Aesthetic Treatment market: Procedure type movement analysis
Figure. 12 U.S.InjecTable market, 2016 - 2028 (USD Million)
Figure. 13 Canada InjecTable market, 2016 - 2028 (USD Million)
Figure. 14 U.S. Botulinum Toxin market, 2016 - 2028 (USD Million)
Figure. 15 Canada Botulinum Toxin market, 2016 - 2028 (USD Million)
Figure. 16 U.S. Calcium Hydroxylapatite market, 2016 - 2028 (USD Million)
Figure. 17 Canada Calcium Hydroxylapatite market, 2016 - 2028 (USD Million)
Figure. 18 Hyaluronic Acid market, 2016 - 2028 (USD Million)
Figure. 19 Canada Hyaluronic Acid market, 2016 - 2028 (USD Million)
Figure. 20 U.S. Polymer fillers market, 2016 - 2028 (USD Million)
Figure. 21 Canada Polymer fillers market, 2016 - 2028 (USD Million)
Figure. 22 Collagen market, 2016 - 2028 (USD Million)
Figure. 23 Canada Collagen market, 2016 - 2028 (USD Million)
Figure. 24 U.S. Skin Rejuvenation market, 2016 - 2028 (USD Million)
Figure. 25 Canada Skin Rejuvenation market, 2016 - 2028 (USD Million)
Figure. 26 U.S. chemical peel market, 2016 - 2028 (USD Million)
Figure. 27 Canada chemical peel market, 2016 - 2028 (USD Million)
Figure. 28 U.S. Laser Skin Resurfacing market, 2016 - 2028 (USD Million)
Figure. 29 Canada Laser Skin Resurfacing market, 2016 - 2028 (USD Million)
Figure. 30 U.S. Photo rejuvenation market, 2016 - 2028 (USD Million)
Figure. 31 Canada Photo rejuvenation market, 2016 - 2028 (USD Million)
Figure. 32 U.S. Other market, 2016 - 2028 (USD Million)
Figure. 33 Canada Other market, 2016 - 2028 (USD Million)
Figure. 34 U.S. hair removal market, 2016 - 2028 (USD Million)
Figure. 35 Canada hair removal market, 2016 - 2028 (USD Million)
Figure. 36 U.S. Non-Surgical Fat Reduction removal market, 2016 - 2028 (USD Million)
Figure. 37 Canada Non-Surgical Fat Reduction removal market, 2016 - 2028 (USD Million)
Figure. 38 U.S. Sclerotherapy market, 2016 - 2028 (USD Million)
Figure. 39 Canada Sclerotherapy market, 2016 - 2028 (USD Million)
Figure. 40 U.S. Cellulite Treatment market, 2016 - 2028 (USD Million)
Figure. 41 Canada Cellulite Treatment market, 2016 - 2028 (USD Million)
Figure. 42 U.S. Non-invasive Aesthetic Treatment market End-use outlook: Segment dashboard : Key takeaways
Figure. 43 U.S. Non-invasive aesthetic treatment market End-use outlook: Segment dashboard , 2020 & 2028
Figure. 44 Canada Non-invasive Aesthetic Treatment market End-use outlook: Segment dashboard : Key takeaways
Figure. 45 Canada Non-invasive Aesthetic Treatment market End-use outlook: Segment dashboard , 2020 & 2028
Figure. 46 U.S. Medspa market, 2016 - 2028 (USD Million)
Figure. 47 Canada Medspa market, 2016 - 2028 (USD Million)
Figure. 48 U.S. Traditional Spa market, 2016 - 2028 (USD Million)
Figure. 49 Canada Traditional Spa market, 2016 - 2028 (USD Million)
Figure. 50 U.S. Hospital and surgery Center market, 2016 - 2028 (USD Million)
Figure. 51 Canada Hospital and surgery Center market, 2016 - 2028 (USD Million)
Figure. 52 U.S.HCP Owned Clinic market, 2016 - 2028 (USD Million)
Figure. 53 Canada HCP Owned Clinic market, 2016 - 2028 (USD Million)
Companies Mentioned
- TORONTO COSMETIC CLINIC
- THE COSMETIC CLINIC
- SKINOVATIVE OF GILBERT - MEDICAL SPA
- SHEA AESTHETIC CLINIC
- CHAPTER (REJUV MEDICAL AESTHETIC CLINIC)
- ANEWSKIN AESTHETIC CLINIC AND MEDICAL SPA
- THE OTTAWA SKIN CLINIC
- MANHATTAN AESTHETICS
- TORONTO MEDICAL AESTHETICS.
- DR. CORY TORGERSON
- CANADA MEDLASER INC.
- SKINRHÜMMD
- SKIN VITALITY MEDICAL CLINIC
- TRUE MEDISPA
- DERMAPURE
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | November 2021 |
| Forecast Period | 2020 - 2028 |
| Estimated Market Value ( USD | $ 17.12 billion |
| Forecasted Market Value ( USD | $ 46.07 billion |
| Compound Annual Growth Rate | 13.2% |
| Regions Covered | North America |
| No. of Companies Mentioned | 15 |
